BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19884294)

  • 1. Managing diabetes in hemodialysis patients: observations and recommendations.
    Shrishrimal K; Hart P; Michota F
    Cleve Clin J Med; 2009 Nov; 76(11):649-55. PubMed ID: 19884294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agents for the treatment of diabetes mellitus.
    O'Mara NB
    Semin Dial; 2010; 23(5):475-9. PubMed ID: 21069919
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.
    Loipl J; Schmekal B; Biesenbach G
    Ren Fail; 2005; 27(3):305-8. PubMed ID: 15957547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Challenges in managing diabetes in chronic hemodialysis].
    Lamine F; Chtioui H; Schwotzer N; Pruijm M; Nobre D; Phan O; Ammor N; Andrey M; Grangier-Bernard P; Zanchi A
    Rev Med Suisse; 2019 May; 15(653):1132-1139. PubMed ID: 31148425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term glycemic control measurements in diabetic patients receiving hemodialysis.
    Joy MS; Cefalu WT; Hogan SL; Nachman PH
    Am J Kidney Dis; 2002 Feb; 39(2):297-307. PubMed ID: 11840370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.
    Biesenbach G; Bodlaj G; Ebner S; Biesenbach P; Pieringer H
    Int Urol Nephrol; 2011 Dec; 43(4):1155-60. PubMed ID: 20640938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of diabetes in dialysis patients.
    Williams ME
    Curr Diab Rep; 2009 Dec; 9(6):466-72. PubMed ID: 19954693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal dialysis in diabetic patients.
    Bertoli M; Bonfante L; Gambaro G; Cara M; Virgilio B; D'Angelo A
    Contrib Nephrol; 2001; (131):51-60. PubMed ID: 11125563
    [No Abstract]   [Full Text] [Related]  

  • 10. The management of terminal renal failure in diabetic patients by regular dialysis therapy.
    White N; Snowden SA; Parsons V; Sheldon J; Bewick M
    Nephron; 1973; 11(5):261-75. PubMed ID: 4753518
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatigue in hemodialysis patients with and without diabetes: results from a randomized controlled trial of two glucose-containing dialysates.
    Raimann JG; Kruse A; Thijssen S; Kuntsevich V; Diaz-Buxo JA; Levin NW; Kotanko P
    Diabetes Care; 2010 Sep; 33(9):e121. PubMed ID: 20805263
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodialysis and effect of corrective measures to prevent hypoglycemia.
    Katla V; Khyalappa R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of diabetes in patients with chronic kidney disease.
    Ahmed Z; Simon B; Choudhury D
    Postgrad Med; 2009 May; 121(3):52-60. PubMed ID: 19491540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes.
    Coca SG; Ismail-Beigi F; Haq N; Krumholz HM; Parikh CR
    Arch Intern Med; 2012 May; 172(10):761-9. PubMed ID: 22636820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease: a pilot study.
    Osonoi T; Saito M; Tamasawa A; Ishida H; Tsujino D; Nishimura R; Utsunomiya K
    PLoS One; 2014; 9(12):e113468. PubMed ID: 25526642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic control and burnt-out diabetes in ESRD.
    Kovesdy CP; Park JC; Kalantar-Zadeh K
    Semin Dial; 2010; 23(2):148-56. PubMed ID: 20374552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis.
    Mirani M; Berra C; Finazzi S; Calvetta A; Radaelli MG; Favareto F; Graziani G; Badalamenti S
    Diabetes Technol Ther; 2010 Oct; 12(10):749-53. PubMed ID: 20809678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-prandial hyperglycaemia--the necessity for better control.
    Del Prato S
    Int J Clin Pract Suppl; 2000 Sep; (112):3-8. PubMed ID: 11064944
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study.
    Singhsakul A; Supasyndh O; Satirapoj B
    J Diabetes Res; 2019; 2019():6923543. PubMed ID: 31828166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus.
    Derosa G; Libetta C; Esposito P; Borettaz I; Tinelli C; D'Angelo A; Maffioli P
    J Diabetes Complications; 2015; 29(8):1136-41. PubMed ID: 26387810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.